TOMI™ Takes Lead on Fight Against C. diff With “List K” Listing

BEVERLY HILLS, Calif., March 13, 2017 -- TOMI™ Environmental Solutions, Inc. (TOMI) (OTCQX:TOMZ), As Clostridium Difficile Spores (C. diff) continue to plague hospitals around the country, the EPA has issued their latest “List K”. List K is to establish a quick reference for those looking for products which are EPA registered and shown to be effective against C. diff Spores. For the first time TOMI’s Binary Ionization Technology®(BIT™) Solution has been added to the most recent list distributed January 27, 2017. (EPA Reg. Number 90150-2.)

“C. diff is truly a nightmare for those who have been inflicted with it. It’s estimated that over 500 thousand Americans contract C. diff infections every year, with 29,000 of them dying.” Says TOMI Scientific Advisory Board Member Dr. Helen Paxton.

List K is comprised of over 50 different solutions and systems, most are spray and wipe chemical products, TOMI’s registration is one of few fogging systems on this list.  Dr. Halden Shane, CEO and Chairman of TOMI Environmental Solutions adds - “Our technology is providing an effective and efficient choice in the way hospitals disinfect. Our EPA registration and our inclusion on this list is important, especially as so many products claim so much, but do not offer the combination of quickness, efficacy and environmental friendliness that SteraMist offers. Getting on List K allows TOMI to continue its ambition to lead in this very important fight against C. diff.”

C. diff is a part of a bigger issue in our hospitals cleaning protocols and can lead to a Hospital Acquired Infections (HAIs) which cost facilities billions of dollars each year, and unfortunately cost patients their lives. EPA Registration (90150-2) also registers TOMI’s SteraMist™ BIT™ system against other common microorganisms which can lead to HAIs including MRSA*, and Pseudomonas.

About TOMI™ Environmental Solutions, Inc.
TOMI^™ Environmental Solutions, Inc. (OTCQX:TOMZ) is a global bacteria decontamination and infectious disease control company, providing eco-friendly environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier platform of using a low percentage Hydrogen Peroxide as its only active ingredient which produces a OH ion through its  Binary Ionization Technology® (BIT^™) , a state of the art technology for the production of its Activated Ionized Hydroxyl Radical  mist represented by the TOMI™ SteraMist™ brand.

TOMI’s products are designed to service a broad spectrum of commercial structures including hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, for non-food safety in meat and produce processing facilities, military barracks, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences.

TOMI also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association, Indoor Air Quality Association, and The International Ozone Association. For additional product information, visit www.tomimist.com or contact us at [email protected].

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release

Disclaimers:
Note listing on EPA “List K” is not an endorsement by the EPA

*SteraMist™ Surface Unit disinfects Staphylococcus aureus (ATCC # 6538), Pseudomonas aeruginosa (ATCC # 15442), Methicillin Resistant Staphylococcus aureus (MRSA) (ATCC # 33592)
For use in mold and mildew control and remediation
**Influenza A (H1N1) virus (ATCC VR-1469)

†SteraMist™ Environment System disinfects Staphylococcus aureus (ATCC # 6538), Pseudomonas aeruginosa (ATCC # 15442), and Clostridium difficile spores (C. diff) (ATCC # 43598)

MEDIA RELATIONS CONTACT:
Paul Varga
Marketing and Communications Manager
(301) 682-2831